Ampio Pharmaceuticals, Inc.
Ampio Pharmaceuticals, Inc. (AMPE): 3 pipeline candidates. Updated within the last hour.
BioSniper Score
3-factor signal · derived from public data
N/A
D/E 0.71 · 0% dilution
Lead: Preclinical
3 candidates
N/A
N/A
A transparent, data-derived signal for Ampio Pharmaceuticals, Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$208K
Cash
$4.1M
Quarterly Burn
—
Runway
—
Revenue
—
Pipeline (3 candidates)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
1
Total value held
$67
| Holder | Shares | Value |
|---|---|---|
| cypress capital management llc (wy) | 440 | $67 |
Frequently asked questions
How many drug candidates are in Ampio Pharmaceuticals, Inc.'s pipeline?
Ampio Pharmaceuticals, Inc. (AMPE) has 3 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Ampio Pharmaceuticals, Inc.'s market capitalization?
Ampio Pharmaceuticals, Inc.'s market capitalization is approximately $208K.
Who is the CEO of Ampio Pharmaceuticals, Inc.?
Mr. Michael A. Martino is the chief executive officer of Ampio Pharmaceuticals, Inc. (AMPE).
Get the full picture on Ampio Pharmaceuticals, Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.